Literature DB >> 24209361

Naphthyridine-based lanthanide complexes worked as magnetic resonance imaging contrast for guanosine 5'-monophosphate in vivo.

Jichuan Kong1, Tao Liu, Yongming Bao, Kun Jin, Xiaolin Zhang, Qin Tang, Chunying Duan.   

Abstract

New lanthanide complex Gd-ANAMD containing 2-amino-7-methyl-1,8-naphthyridine was achieved for selective magnetic resonance imaging towards guanosine 5'-monophosphate over other ribonucleotide polyphosphates in aqueous media and in vivo. The formation of strong multi-hydrogen bonds between naphthyridine and guanosine made the phosphate in guanosine 5'-monophosphate positioned on a suitable site to coordinate with the lanthanide ion. The substitution of the coordination naphthyridine by the phosphate oxygen atoms caused obvious relaxivity decrease. The negligible cytotoxicity and appropriate blood circulation time of Gd-ANAMD allow potential application of Magnetic Resonance Imaging in vivo. (1)H NMR confirmed that the selectivity of these lanthanide complexes towards guanosine was attributed to the formation of hydrogen bonds between the guanine moeity and the naphthyridine. The fluorescence detection and lifetime measurement of Tb-ANAMD and Eu-ANAMD suggested that the decrease of the relaxivity is not attributed to the change of the q value, but caused by the prolonging of the residence lifetime of inner-sphere water.
© 2013 Published by Elsevier B.V.

Entities:  

Keywords:  Chemosensor; Gd; Guanosine 5′-monophosphate; Magnetic resonance imaging; Naphthyridine

Mesh:

Substances:

Year:  2013        PMID: 24209361     DOI: 10.1016/j.talanta.2013.09.020

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  1 in total

1.  Luminescence Sensitization of Eu(III) Complexes with Aromatic Schiff Base and N,N'-Donor Heterocyclic Ligands: Synthesis, Luminescent Properties and Energy Transfer.

Authors:  Manju Sengar; Anudeep Kumar Narula
Journal:  J Fluoresc       Date:  2018-10-27       Impact factor: 2.217

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.